BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
6.40
+2.10 (48.84%)
At close: Apr 24, 2026

BHIC Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
734442368--
Market Cap Growth
-4.32%-88.55%---
Enterprise Value
724342368--
Last Close Price
6.404.004.0036.0432.0015.00
PE Ratio
109.4368.40483.87---
PS Ratio
12.797.7222.82615.03--
PB Ratio
49.2429.7350.40-54370.02--
P/TBV Ratio
52.1731.4952.02---
P/OCF Ratio
422.53255.061815.43---
EV/Sales Ratio
12.677.5622.66615.10--
EV/EBIT Ratio
100.2559.81480.43---
Debt / Equity Ratio
----12.88-2.64-1.10
Net Debt / Equity Ratio
-0.45-0.45-0.79-10.03-1.97-1.00
Asset Turnover
4.414.413.829.564.37-
Inventory Turnover
12.4112.4111.174.53--
Quick Ratio
5.225.2220.350.560.400.09
Current Ratio
6.786.7821.990.930.650.09
Return on Equity (ROE)
55.53%55.53%21.00%---
Return on Assets (ROA)
34.83%34.83%11.24%-251.51%-442.83%-
Return on Invested Capital (ROIC)
79.50%129.96%74.42%-647.53%-1353.05%-
Return on Capital Employed (ROCE)
48.70%48.70%10.40%3720.40%653.70%608.40%
Earnings Yield
0.88%1.46%0.21%-0.07%--
Buyback Yield / Dilution
-4.54%-4.54%-29.17%-301.99%-147.38%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.